Frontiers in Cardiovascular Medicine (Apr 2021)
Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR
- Lei Li,
- Lei Li,
- Lei Li,
- Maozhou Wang,
- Maozhou Wang,
- Maozhou Wang,
- Jinzhang Li,
- Jinzhang Li,
- Jinzhang Li,
- Xinliang Guan,
- Xinliang Guan,
- Xinliang Guan,
- Pu Xin,
- Pu Xin,
- Pu Xin,
- Xiaolong Wang,
- Xiaolong Wang,
- Xiaolong Wang,
- Yuyong Liu,
- Yuyong Liu,
- Yuyong Liu,
- Haiyang Li,
- Haiyang Li,
- Haiyang Li,
- Wenjian Jiang,
- Wenjian Jiang,
- Wenjian Jiang,
- Ming Gong,
- Ming Gong,
- Ming Gong,
- Hongjia Zhang,
- Hongjia Zhang,
- Hongjia Zhang
Affiliations
- Lei Li
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Lei Li
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Lei Li
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Maozhou Wang
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Maozhou Wang
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Maozhou Wang
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Jinzhang Li
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Jinzhang Li
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Jinzhang Li
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Xinliang Guan
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Xinliang Guan
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Xinliang Guan
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Pu Xin
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Pu Xin
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Pu Xin
- Department of Medical Imaging, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Xiaolong Wang
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Xiaolong Wang
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Xiaolong Wang
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Yuyong Liu
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Yuyong Liu
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Yuyong Liu
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Haiyang Li
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Haiyang Li
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Haiyang Li
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Wenjian Jiang
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Wenjian Jiang
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Wenjian Jiang
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Ming Gong
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Ming Gong
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Ming Gong
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- Hongjia Zhang
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- Hongjia Zhang
- Beijing Aortic Disease Center, Cardiovascular Surgery Center, Beijing, China
- Hongjia Zhang
- Beijing Lab for Cardiovascular Precision Medicine, Beijing, China
- DOI
- https://doi.org/10.3389/fcvm.2021.658952
- Journal volume & issue
-
Vol. 8
Abstract
Objective: To determine the effect of renal artery stenosis (RAS) resulting from acute type B aortic dissection (ATBAD) with thoracic endovascular aortic repair (TEVAR) on early prognosis in patients with ATBAD.Methods: A total of 129 ATBAD patients in the National Acute Aortic Syndrome Database (AASCN) who underwent TEVAR between 2019 and 2020 were enrolled in our study. Patients were divided into two groups: the RAS group and the non-RAS group.Results: There were 21 RAS patients (16.3%) and 108 non-RAS patients (83.7%) in our cohort. No patient in our cohort died during the 1-month follow-up. There was no significant difference in preoperative creatinine clearance rate (CCr) between the two groups (90.6 ± 46.1 μmol/L in the RAS group vs. 78.7 ± 39.2 μmol/L in the non-RAS group, P = 0.303) but the RAS group had a significantly lower estimated glomerular filtration rate (eGFR) than the non-RAS group (83.3 ± 25.0 vs. 101.9 ± 26.9 ml/min, respectively; P = 0.028).One month after TEVAR, CCr was significantly higher (99.0 ± 68.1 vs. 78.5 ± 25.8 ml/min, P = 0.043) and eGFR (81.7 ± 23.8 vs. 96.0 ± 20.0 ml/min, P = 0.017) was significantly lower in the RAS group than in the non-RAS group.Conclusions: In ATBAD, RAS could result in acute kidney injury (AKI) in the early stage after TEVAR. The RAS group had a high incidence of hypertension. These results suggest that patients with RAS may need further treatment.
Keywords
- renal artery stenosis
- acute type B aortic dissection
- acute kidney injury
- hypertension
- early prognosis
